Differentiated Thyroid Cancer—Treatment: State of the Art

Author： Schmidbauer Benedikt   Menhart Karin   Hellwig Dirk   Grosse Jirka  

Publisher： MDPI

E-ISSN： 1422-0067|18|6|1292-1292

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.18, Iss.6, 2017-06, pp. : 1292-1292

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

State of Art of Cancer Pharmacogenomics in Latin American Populations

By López-Cortés Andrés   Guerrero Santiago   Redal María Ana   Alvarado Angel Tito   Quiñones Luis Abel  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-05 ,pp. : 639-639

MDPI

Access to resources Recommend Favorite

The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors

By Ancker Ole Vincent   Wehland Markus   Bauer Johann   Infanger Manfred   Grimm Daniela  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 625-625

MDPI

Access to resources Recommend Favorite

State of the Art in Silico Tools for the Study of Signaling Pathways in Cancer

By Villaamil Vanessa Medina   Gallego Guadalupe Aparicio   Cainzos Isabel Santamarina   Valladares-Ayerbes Manuel   Antón Aparicio Luis M.  

International Journal of Molecular Sciences, Vol. 13, Iss. 6, 2012-05 ,pp. : 6561-6581

MDPI

Access to resources Recommend Favorite

Ingested Type I Interferon—State of the Art as Treatment for Autoimmunity Part 2

By Brod Staley A.  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1108-1121

MDPI

Access to resources Recommend Favorite

Molecular Therapies in Thyroid Cancer

By Huyck Timothy   Agulnik Mark  

Pharmaceuticals, Vol. 4, Iss. 1, 2010-12 ,pp. : 91-100

MDPI

Access to resources Recommend Favorite